Major Bayer shareholder Harris backs CEO’s focus on internal restructuring
Business & FinanceHealth 07 March 2024, 1:56 pm 1 minute Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO. Market Impact The news caused Bayer’s shares to significantly narrow…